Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123869864 | 12386986 | 4 | F | 2016 | 20160826 | 20160519 | 20160909 | EXP | CA-VALIDUS PHARMACEUTICALS LLC-CA-2016VAL001582 | VALIDUS | 0.00 | Y | 0.00000 | 20160909 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123869864 | 12386986 | 1 | PS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | UNK | U | 17963 | ||||||||||
| 123869864 | 12386986 | 2 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO (ONCE A MONTH); (SANDOSTATIN LAR) | U | 0 | 20 | MG | |||||||
| 123869864 | 12386986 | 3 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 4 WEEKS); (SANDOSTATIN LAR) | U | 0 | 30 | MG | |||||||
| 123869864 | 12386986 | 4 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG, QMO | U | 0 | 40 | MG | |||||||
| 123869864 | 12386986 | 5 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | UNK ?G, QD (X3 DAYS CONSECUTIVELY) | 0 | ||||||||||
| 123869864 | 12386986 | 6 | C | NORVASC | AMLODIPINE BESYLATE | 1 | UNK | U | 0 | ||||||||||
| 123869864 | 12386986 | 7 | C | ASAPHEN | ASPIRIN | 1 | UNK | U | 0 | ||||||||||
| 123869864 | 12386986 | 8 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123869864 | 12386986 | 1 | Product used for unknown indication |
| 123869864 | 12386986 | 2 | Carcinoid syndrome |
| 123869864 | 12386986 | 5 | Carcinoid tumour |
| 123869864 | 12386986 | 6 | Product used for unknown indication |
| 123869864 | 12386986 | 7 | Product used for unknown indication |
| 123869864 | 12386986 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123869864 | 12386986 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123869864 | 12386986 | Blood pressure diastolic decreased | |
| 123869864 | 12386986 | Blood pressure systolic increased | |
| 123869864 | 12386986 | Body temperature decreased | |
| 123869864 | 12386986 | Diarrhoea | |
| 123869864 | 12386986 | Haematochezia | |
| 123869864 | 12386986 | Therapeutic response decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123869864 | 12386986 | 2 | 20160115 | 20160408 | 0 | |
| 123869864 | 12386986 | 3 | 20160506 | 20160704 | 0 | |
| 123869864 | 12386986 | 4 | 20160801 | 0 | ||
| 123869864 | 12386986 | 5 | 20160111 | 20160113 | 0 |